NORDTREAT: a randomised, multicentre, biomarker-strategy design, open-label, controlled trial of top-down versus clinical management in newly diagnosed IBD. - Bergemalm, D.; Füchtbauer, D.; Rejller, M.; Davíðsdóttir, L.; Fejrskov, A.; Hedin, C. R.; Bache-WiigMathisen, C.; Hupperz-Hauss, G.; Carstens, A.; Kristensen, V.; Hjortswang, H.; Aabrekk, T. B.; et al. (Journal of Crohn's & Colitis, 2026)